TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 15.6nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 7.26nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 19.3nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 692nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 17nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 6.08nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 16.5nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 21nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 4.35nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 8.81nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 21.3nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 10.7nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 22.7nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 17.3nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 28.9nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 55nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 98.4nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 254nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 75.8nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 0.585nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 3.32nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 0.276nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 0.249nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 2.80nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 1.76nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 1.28nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 7.27nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 2.03nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 5.97nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 6.02nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 5.63nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 1nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 3.17nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 6.65nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 77.7nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 0.725nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 130nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 214nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 35nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 85.2nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 970nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 105nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 21.9nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 3.78E+3nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 38.5nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 25.2nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 44nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 52.8nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 1.13E+3nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Board of Trustees of The Southern Illinois University
US Patent
Board of Trustees of The Southern Illinois University
US Patent
Affinity DataEC50: 2.71E+3nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)